What is NDC 71335-3075?

71335-3075 is the product NDC for Naproxen Sodium, Naproxen sodium 550 mg/1 tablet, listed with the FDA by Bryant Ranch Prepack. It has 10 package NDCs, shown above in 10- and 11-digit form.

Bryant Ranch Prepack, NDC labeler code 71335. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Naproxen Sodium?

144 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Naproxen Sodium NDC 71335-3075 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)71335-3075Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71335-3075Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
71335-3075-0	7133530750071335307500	6 TABLET in 1 BOTTLE (71335-3075-0)Marketed from Feb 9, 2026
71335-3075-1	7133530750171335307501	20 TABLET in 1 BOTTLE (71335-3075-1)Marketed from Feb 9, 2026
71335-3075-2	7133530750271335307502	100 TABLET in 1 BOTTLE (71335-3075-2)Marketed from Feb 9, 2026
71335-3075-3	7133530750371335307503	30 TABLET in 1 BOTTLE (71335-3075-3)Marketed from Feb 9, 2026
71335-3075-4	7133530750471335307504	120 TABLET in 1 BOTTLE (71335-3075-4)Marketed from Feb 9, 2026
71335-3075-5	7133530750571335307505	60 TABLET in 1 BOTTLE (71335-3075-5)Marketed from Feb 9, 2026
71335-3075-6	7133530750671335307506	90 TABLET in 1 BOTTLE (71335-3075-6)Marketed from Feb 9, 2026
71335-3075-7	7133530750771335307507	42 TABLET in 1 BOTTLE (71335-3075-7)Marketed from Feb 9, 2026
71335-3075-8	7133530750871335307508	14 TABLET in 1 BOTTLE (71335-3075-8)Marketed from Feb 9, 2026
71335-3075-9	7133530750971335307509	56 TABLET in 1 BOTTLE (71335-3075-9)Marketed from Feb 9, 2026

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Naproxen Sodium
Generic name (nonproprietary): naproxen sodium
Active ingredients: Naproxen sodium — 550 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Bryant Ranch PrepackNDC labeler code 71335
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 078314
Marketing start: Aug 1, 2007
Listing expires: Dec 31, 2027
Other FDA classes: Non-Steroidal (Chemical structure)Cyclooxygenase Inhibitors (Mechanism)
Identifiers: Product ID 71335-3075_405bbf1d-085e-461b-9b57-102cafa88a4fSPL ID 405bbf1d-085e-461b-9b57-102cafa88a4fSPL set ID 83dd8829-7ba0-4a8d-a979-41a5e077c49fRxCUI 849431UNII 9TN87S3A3C
Pharmacologic class: Nonsteroidal Anti-inflammatory Drug

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471335307500 followed by a unit qualifier and the quantity

Package 71335-3075-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 9, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Naproxen tablets and naproxen sodium tablets are indicated for: the relief of the signs and symptoms of: • rheumatoid arthritis • osteoarthritis • ankylosing spondylitis • Polyarticular Juvenile Idiopathic Arthritis Naproxen tablets and naproxen sodium tablets are also indicated for: the relief of signs and symptoms of: • tendonitis • bursitis • acute gout the management of: • pain • primary dysmenorrhea Naproxen tablets and naproxen sodium tablets are non-steroidal anti-inflammatory drugs indicated for: the relief of the signs and symptoms of: • rheumatoid arthritis • osteoarthritis • ankylosing spondylitis • polyarticular juvenile idiopathic arthritis Naproxen tablets and naproxen sodium t…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 71335-3075

What is NDC 71335-3075?: 71335-3075 is the product NDC for Naproxen Sodium, Naproxen sodium 550 mg/1 tablet, listed with the FDA by Bryant Ranch Prepack. It has 10 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Naproxen Sodium.
What is the active ingredient?: Naproxen sodium.
Who is the labeler?: Bryant Ranch Prepack, NDC labeler code 71335. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Naproxen Sodium?: 144 other product NDCs are listed under this name. See all Naproxen Sodium NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Naproxen Sodium NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
naproxen sodium	Naproxen sodium 220 mg/1	Tablet, Film coatedOral	Amazon.com Services LLC	72288-988	72288-0988-75
Naproxen Sodium	Naproxen sodium 220 mg/1	Tablet, CoatedOral	AAA Pharmaceutical, Inc.	57344-244	57344-0244-03
Naproxen Sodium	Naproxen sodium 550 mg/1	TabletOral	Advanced Rx of Tennessee, LLC	80425-0574	80425-0574-0180425-0574-0280425-0574-03
Naproxen Sodium	Naproxen sodium 220 mg/1	Tablet, CoatedOral	HYVEE INC	42507-245	42507-0245-0142507-0245-0842507-0245-14
Naproxen Sodium	Naproxen sodium 220 mg/1	Tablet, CoatedOral	HYVEE INC	42507-844	42507-0844-0142507-0844-14
Naproxen Sodium	Naproxen sodium 220 mg/1	Capsule, Liquid filledOral	TARGET Corporation	11673-651	11673-0651-78
Naproxen Sodium	Naproxen sodium 220 mg/1	Tablet, Film coatedOral	Safeway	21130-593	21130-0593-79
Naproxen Sodium	Naproxen sodium 550 mg/1	TabletOral	Advanced Rx of Tennessee, LLC	80425-0531	80425-0531-0180425-0531-0280425-0531-03
Naproxen Sodium	Naproxen sodium 550 mg/1	TabletOral	Advanced Rx of Tennessee, LLC	80425-0532	80425-0532-0180425-0532-0280425-0532-03
Naproxen Sodium	Naproxen sodium 220 mg/1	Tablet, CoatedOral	CHAIN DRUG MARKETING ASSOCIATION, INC.	83324-108	83324-0108-0183324-0108-2483324-0108-50

All 145 Naproxen Sodium NDCs

Other NDCs under ANDA 078314

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 078314
Product	Strength	Form · route	Labeler	Product NDC
Naproxen Sodium	Naproxen sodium 275 mg/1	TabletOral	Glenmark Pharmaceuticals Inc., USA	68462-178
Naproxen Sodium	Naproxen sodium 550 mg/1	TabletOral	Glenmark Pharmaceuticals Inc., USA	68462-179
Naproxen Sodium	Naproxen sodium 550 mg/1	TabletOral	Advanced Rx of Tennessee, LLC	80425-0532